Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in israel
- 30 June 2003
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 89 (3) , 494-498
- https://doi.org/10.1016/s0090-8258(03)00152-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Parity, Oral Contraceptives, and the Risk of Ovarian Cancer among Carriers and Noncarriers of aBRCA1orBRCA2MutationNew England Journal of Medicine, 2001
- Founder BRCA 1 and 2 Mutations among a Consecutive Series of Ashkenazi Jewish Ovarian Cancer PatientsGynecologic Oncology, 2000
- BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian CancerAmerican Journal of Human Genetics, 2000
- Founder BRCA1/2 Mutations among Male Patients with Breast Cancer in IsraelAmerican Journal of Human Genetics, 1999
- A population-based study of BRCA1 and BRCA2 mutations in jewish women with epithelial ovarian cancerPublished by Wolters Kluwer Health ,1999
- High Frequency of BRCA1 and BRCA2 Germline Mutations in Ashkenazi Jewish Ovarian Cancer Patients, Regardless of Family HistoryGynecologic Oncology, 1997
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- High frequency of BRCA1 185delAG mutation in ovarian cancer in Israel. National Israel Study of Ovarian CancerPublished by American Medical Association (AMA) ,1996
- Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer familiesNature Medicine, 1996
- Common origins of BRCA1 mutations in Canadian breast and ovarian cancer familiesNature Genetics, 1994